In this issue:
Does organic food consumption reduce cancer risk?
Hybrid minimally invasive oesophagectomy
Adjuvant FOLFIRINOX or gemcitabine in pancreatic cancer
NAB-paclitaxel + gemcitabine in metastatic pancreatic adenocarcinoma
UGT1A1 genotype-guided dosing of mFOLFIRINOX
Cost burden of checkpoint inhibition for MSI-H/dMMR mCRC
Competing mortality in cancer survivors
Diet quality and CRC survival
Bevacizumab efficacy is independent of tumour location in mCRC
Adjuvant CTX after resection of
pulmonary metastases from CRC
Please login below to download this issue (PDF)